Cocrystal Pharma, Inc.

COCP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$7,729$4,766$6,921$9,860
Short-Term Investments$0$0$0$0
Receivables$0$1,642$1,445$1,215
Inventory$0$0$0$0
Other Curr. Assets$1,053$357$460$505
Total Curr. Assets$8,782$6,765$8,826$11,580
Property Plant & Equip (Net)$1,574$1,652$1,747$1,847
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$90$88$86$29
Total NC Assets$1,664$1,740$1,833$1,876
Other Assets$0$0$0$0
Total Assets$10,446$8,505$10,659$13,456
Liabilities
Payables$0$856$808$1,542
Short-Term Debt$326$317$309$301
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,194$658$814$585
Total Curr. Liab.$1,520$1,831$1,931$2,428
LT Debt$1,257$1,341$1,424$1,505
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,257$1,341$1,424$1,505
Other Liabilities$0$0$0$0
Cap. Leases$0$1,658$1,733$1,806
Total Liabilities$2,777$3,172$3,355$3,933
Equity
Pref Stock$0$0$0$0
Common Stock$13$10$10$10
Retained Earnings-$339,823-$337,774-$335,719-$333,418
AOCI$0$0$0$0
Other Equity$347,479$343,097$343,013$342,931
Total Equity$7,669$5,333$7,304$9,523
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,446$8,505$10,659$13,456
Net Debt-$6,146-$3,108-$5,188-$8,054
Cocrystal Pharma, Inc. (COCP) Financial Statements & Key Stats | AlphaPilot